(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 2.95% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.74%.
Dentsply Sirona's revenue in 2025 is $3,624,000,000.On average, 18 Wall Street analysts forecast XRAY's revenue for 2026 to be $747,122,571,936, with the lowest XRAY revenue forecast at $694,241,300,151, and the highest XRAY revenue forecast at $789,228,037,395. On average, 17 Wall Street analysts forecast XRAY's revenue for 2027 to be $765,281,801,115, with the lowest XRAY revenue forecast at $711,003,665,547, and the highest XRAY revenue forecast at $818,362,624,869.
In 2028, XRAY is forecast to generate $792,221,316,930 in revenue, with the lowest revenue forecast at $751,512,715,254 and the highest revenue forecast at $822,154,112,280.